Stimulation of CD40 in human bladder carcinoma cells inhibits anti-Fas/APO-1 (CD95)-induced apoptosis

被引:0
|
作者
Jakobson, E [1 ]
Jönsson, G [1 ]
Björck, P [1 ]
Paulie, S [1 ]
机构
[1] Univ Stockholm, Dept Immunol, S-10691 Stockholm, Sweden
关键词
D O I
10.1002/(SICI)1097-0215(19980911)77:6<849::AID-IJC9>3.0.CO;2-U
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
CD40 and the CD95 (Fas/APO-1 antigen) are both members of the tumor necrosis factor receptor family. Whereas CD40 mediates a strong growth stimulatory signal in B cells, engagement of the CD95 receptor leads to growth inhibition and induction of apoptosis. As it has been reported that CD40 activation may rescue B cells from undergoing apoptosis, we were interested to see whether it had a similar effect in other cells expressing the CD40 receptor. We used epithelial tumor cells from the urinary bladder, a cell type that frequently expresses CD40 but for which no clear function of the molecule has been assigned. We found that the ligation of CD95 with the antibody anti-APO-l induced apoptosis in most of the cell lines tested. Stimulation of CD40 with antibodies or a soluble construct of the CD40 ligand was shown to protect cells from apoptosis, as demonstrated by their ability to suppress the growth inhibition exerted by the anti-APO-l antibody. Our results show that CD40 stimulation make cells less vulnerable to apoptosis induced via CD95 and suggest that CD40 expression on epithelial tumors may be associated with cell survival. (C) 1998 Wiley-Liss, Inc.
引用
收藏
页码:849 / 853
页数:5
相关论文
共 50 条
  • [41] CD95 (Fas/Apo-1)-induced apoptosis results in loss of glucose transporter function
    Berridge, MV
    Tan, AS
    McCoy, KD
    Kansara, M
    Rudert, F
    JOURNAL OF IMMUNOLOGY, 1996, 156 (11): : 4092 - 4099
  • [42] DIFFERENTIAL EXPRESSION OF APO-1 (FAS/CD95) ON HUMAN HEMATOPOIETIC-CELLS
    STAHNKE, K
    KLEIHAUER, E
    DEBATIN, KM
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) : 888 - 888
  • [43] OPPOSING ROLES OF CD95 (FAS/APO-1) AND CD40 IN THE DEATH AND RESCUE OF HUMAN LOW-DENSITY TONSILLAR B-CELLS
    CLEARY, AM
    FORTUNE, SM
    YELLIN, MJ
    CHESS, L
    LEDERMAN, S
    JOURNAL OF IMMUNOLOGY, 1995, 155 (07): : 3329 - 3337
  • [44] Evaluation of CD95 (APO-1/FAS) and the CD95 ligand in acute myelogenous leukemia
    Mestice, A
    Specchia, G
    Coppi, MR
    Palumbo, G
    Carluccio, P
    Attolico, I
    Quarta, A
    Liso, V
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 74 - 74
  • [45] CD95 (APO-1/FAS)-mediated apoptosis in cytokine-activated hematopoietic cells
    Stahnke, K
    Hecker, S
    Kohne, E
    Debatin, KM
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (09) : 844 - 850
  • [46] Triggering of the B cell antigen receptor prevents CD95 (apo-1/fas) mediated apoptosis of CD40 ligand-activated B cells
    Daniel, PT
    Hempel, C
    Bommert, K
    Bargou, RC
    Mapara, MY
    Dorken, B
    BLOOD, 1996, 88 (10) : 640 - 640
  • [47] Characterization of Fas (Apo-1, CD95)-Fas ligand interaction
    Schneider, P
    Bodmer, JL
    Holler, N
    Mattmann, C
    Scuderi, P
    Terskikh, A
    Peitsch, MC
    Tschopp, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (30) : 18827 - 18833
  • [48] The APO-1/Fas (CD95) system is involved in bile-acid induced apoptosis in human hepatocytes
    Smolarek, C
    Strand, S
    Krammer, PH
    Stremmel, W
    Galle, PR
    HEPATOLOGY, 1996, 24 (04) : 956 - 956
  • [49] The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems
    Walczak, H
    Krammer, PH
    EXPERIMENTAL CELL RESEARCH, 2000, 256 (01) : 58 - 66
  • [50] CD95 (APO-1/Fas)-associating signalling proteins
    Peter, ME
    Kischkel, FC
    Hellbardt, S
    Chinnaiyan, AM
    Krammer, PH
    Dixit, VM
    CELL DEATH AND DIFFERENTIATION, 1996, 3 (02): : 161 - 170